[ad_1] CAMBRIDGE, Mbadachusetts – (Business Wire) – Vedanta Biosciences a subsidiary of PureTech Health (LSE: PRTC) developing a new category of therapies Immune-mediated and infectious diseases based on a rational definition consortia …
Read More »Vedanta Biosciences Receives an Award from the Crohn & Colitis Foundation for the Advancement of a Microbiome-Derived Therapeutic Program for the Interception and Treatment of Inflammatory Bowel Diseases – Communiqué Press
